Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years. Ehrenreich H, Neubauer AP, Miskowiak K. JAMA 2021;325:1470-1471.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ehrenreich H, Neubauer AP, Miskowiak K. Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years. JAMA 2021;325:1470-1471.
PMID: 33847720